Circadian disruption is being increasingly recognized as a critical factor in the development and progression of Parkinson’s disease (PD). This review aims to provide an in-depth overview of the relationship between circadian disruption and PD by exploring the molecular, cellular, and behavioral aspects of this interaction. This review will include a comprehensive understanding of how the clock gene system and transcription–translation feedback loops function and how they are diminished in PD. The article also discusses the role of clock genes in the regulation of circadian rhythms, as well as the impact of clock gene dysregulation on mitochondrial function, oxidative stress, and neuroinflammation, including the microbiota-gut-brain axis, which have all been proposed as being crucial mechanisms in the pathophysiology of PD. Finally, this review highlights potential therapeutic strategies targeting the clock gene system and circadian rhythm for the treatment of PD.
Parkinson’s disease (PD) is a common neurodegenerative disorder arising from an interplay between genetic and environmental risk factors. Studies have suggested that the pathological hallmarks of intraneuronal α-synuclein aggregations may start from the olfactory bulb and the enteric nervous system of the gut and later propagate to the brain via the olfactory tract and the vagus nerve. This hypothesis correlates well with clinical symptoms, such as constipation, that may develop up to 20 years before the onset of PD motor symptoms. Recent interest in the gut–brain axis has led to vigorous research into the gastrointestinal pathology and gut microbiota changes in patients with PD. In this review, we provide current clinical and pathological evidence of gut involvement in PD by summarizing the changes in gut microbiota composition and gut inflammation associated with its pathogenesis.
Citations
Citations to this article as recorded by
Adipose tissue, systematic inflammation, and neurodegenerative diseases AnaPaula de A. Boleti, PedroHenrique de O. Cardoso, BrenoEmanuel F. Frihling, PatríciaSouza e Silva, LuizFilipe R. N. de Moraes, Ludovico Migliolo Neural Regeneration Research.2023; 18(1): 38. CrossRef
Parkinson's Disease: A Multisystem Disorder Helena Nunes Costa, Ana Raquel Esteves, Nuno Empadinhas, Sandra Morais Cardoso Neuroscience Bulletin.2023; 39(1): 113. CrossRef
Brain modulation by the gut microbiota: From disease to therapy Sarmistha Mitra, Raju Dash, Amena Al Nishan, Sarmin Ummey Habiba, Il Soo Moon Journal of Advanced Research.2023; 53: 153. CrossRef
Plasma Metabolic Analysis Reveals the Dysregulation of Short-Chain Fatty Acid Metabolism in Parkinson’s Disease Ao Qi, Lulu Liu, Junjie Zhang, Simei Chen, Simin Xu, Yusen Chen, Lijiang Zhang, Chun Cai Molecular Neurobiology.2023; 60(5): 2619. CrossRef
Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study Herbert L. DuPont, Jessika Suescun, Zhi-Dong Jiang, Eric L. Brown, Heather T. Essigmann, Ashley S. Alexander, Andrew W. DuPont, Tehseen Iqbal, Netanya S. Utay, Michael Newmark, Mya C. Schiess Frontiers in Neurology.2023;[Epub] CrossRef
Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases Mohamed S. Attia, Ahmed Yahya, Nada Abdel Monaem, Shereen A. Sabry Saudi Pharmaceutical Journal.2023; 31(3): 417. CrossRef
GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease Bingwei Wang, Yan Ma, Sheng Li, Hang Yao, Mingna Gu, Ying Liu, You Xue, Jianhua Ding, Chunmei Ma, Shuo Yang, Gang Hu Acta Pharmaceutica Sinica B.2023; 13(6): 2663. CrossRef
Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease Júlio César Claudino dos Santos, Leandro Freitas Oliveira, Felipe Micelli Noleto, Camilla Teixeira Pinheiro Gusmão, Gerly Anne de Castro Brito, Glauce Socorro de Barros Viana Neural Regeneration Research.2023; 18(12): 2611. CrossRef
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human Martina Montanari, Paola Imbriani, Paola Bonsi, Giuseppina Martella, Antonella Peppe Biomedicines.2023; 11(6): 1560. CrossRef
Effects of gut microbiota on neurodegenerative diseases Saima Khatoon, Nida Kalam, Summya Rashid, Gulnaz Bano Frontiers in Aging Neuroscience.2023;[Epub] CrossRef
From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes Frances Widjaja, Ivonne M. C. M. Rietjens Biomedicines.2023; 11(10): 2658. CrossRef
Association between the risk and severity of Parkinson’s disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis Yuxin Quan, Jisen Xu, Qing Xu, Zhiqing Guo, Ruwei Ou, Huifang Shang, Qianqian Wei Frontiers in Aging Neuroscience.2023;[Epub] CrossRef
Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease Ehraz Anis, Aoji Xie, Lena Brundin, Patrik Brundin Trends in Endocrinology & Metabolism.2022; 33(2): 147. CrossRef
Animal models of brain-first and body-first Parkinson's disease Nathalie Van Den Berge, Ayse Ulusoy Neurobiology of Disease.2022; 163: 105599. CrossRef
Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study Brian Bicknell, Ann Liebert, Craig S. McLachlan, Hosen Kiat Journal of Personalized Medicine.2022; 12(1): 49. CrossRef
Passive Immunization in Alpha-Synuclein Preclinical Animal Models Jonas Folke, Nelson Ferreira, Tomasz Brudek, Per Borghammer, Nathalie Van Den Berge Biomolecules.2022; 12(2): 168. CrossRef
Dietary Succinoglycan Riclin Improves Glycemia Control in Mice with Type 2 Diabetes Zhao Ding, Yang Zhao, Junhao Liu, Wenhao Ge, Xi Xu, Shiming Wang, Jianfa Zhang Journal of Agricultural and Food Chemistry.2022; 70(6): 1819. CrossRef
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, Andras Hajnal, Mihai Covasa Biomedicines.2022; 10(2): 436. CrossRef
Distribution of α-Synuclein Aggregation in the Peripheral Tissues Yan-yan Li, Tian-tian Zhou, Yi Zhang, Nai-Hong Chen, Yu-He Yuan Neurochemical Research.2022; 47(12): 3627. CrossRef
Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice Jiajing Shan, Youge Qu, Jiancheng Zhang, Li Ma, Kenji Hashimoto Clinical Psychopharmacology and Neuroscience.2022; 20(2): 389. CrossRef
Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies Mie Kristine Just, Hjalte Gram, Vasileios Theologidis, Poul Henning Jensen, K. Peter R. Nilsson, Mikael Lindgren, Karoline Knudsen, Per Borghammer, Nathalie Van Den Berge Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients María Romo-Vaquero, Emiliano Fernández-Villalba, Ana-Luisa Gil-Martinez, Lorena Cuenca-Bermejo, Juan Carlos Espín, María Trinidad Herrero, María Victoria Selma Food & Function.2022; 13(11): 6306. CrossRef
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease Hiroshi Nishiwaki, Mikako Ito, Tomonari Hamaguchi, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Takumi Yoshida, Hiroyuki Hanada, Ichiro Takeuchi, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno npj Parkinson's Disease.2022;[Epub] CrossRef
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson’s Disease “Off” Episodes Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han, Alan D. Kaye Health Psychology Research.2022;[Epub] CrossRef
The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases George Tsafaras, Veerle Baekelandt Neurobiology of Disease.2022; 172: 105806. CrossRef
What Is the Prognostic Significance of Rapid Eye Movement Sleep Without Atonia in a Polysomnogram? Frank Ralls, Lisa Cutchen, Madeleine M. Grigg-Damberger Journal of Clinical Neurophysiology.2022; 39(5): 346. CrossRef
Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism Jose Ivo A. Beserra-Filho, Amanda Maria-Macêdo, Suellen Silva-Martins, Ana Cláudia Custódio-Silva, Beatriz Soares-Silva, Sara Pereira Silva, Rafael Herling Lambertucci, Adriano Antunes de Souza Araújo, Angélica Maria Lucchese, Lucindo J. Quintans-Júnior, Metabolic Brain Disease.2022; 37(7): 2331. CrossRef
Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease Sungyang Jo, Woorim Kang, Yun Su Hwang, Seung Hyun Lee, Kye Won Park, Mi Sun Kim, Hyunna Lee, Hyung Jeong Yoon, Yoo Kyoung Park, Mauricio Chalita, Je Hee Lee, Hojun Sung, Jae-Yun Lee, Jin-Woo Bae, Sun Ju Chung npj Parkinson's Disease.2022;[Epub] CrossRef
Deciphering Intertwined Molecular Pathways Underlying Metabolic Syndrome Leading to Parkinson’s Disease Ritu Soni, Jigna Shah ACS Chemical Neuroscience.2022; 13(15): 2240. CrossRef
Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders Sarika Yadav, Ashish Dwivedi, Anurag Tripathi, Amit Kumar Tripathi Nutrition Research.2022; 106: 72. CrossRef
Development of neurodegenerative disorders and the role of gut Woong-Woo Lee Journal of Geriatric Neurology.2022; 1(2): 53. CrossRef
What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review Bruno Bonnechère, Najaf Amin, Cornelia van Duijn International Journal of Molecular Sciences.2022; 23(22): 13665. CrossRef
Gut microbiota in dementia with Lewy bodies Hiroshi Nishiwaki, Jun Ueyama, Kenichi Kashihara, Mikako Ito, Tomonari Hamaguchi, Tetsuya Maeda, Yoshio Tsuboi, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno npj Parkinson's Disease.2022;[Epub] CrossRef
Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction Justin Cho, You Jeong Park, Bella Gonzales‐Portillo, Madeline Saft, Blaise Cozene, Nadia Sadanandan, Cesar V. Borlongan CNS Neuroscience & Therapeutics.2021; 27(5): 505. CrossRef
Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin Journal of Parkinson's Disease.2021; 11(3): 1129. CrossRef
Parkinson's disease and the gut: Models of an emerging relationship Adam J. Bindas, Subhash Kulkarni, Ryan A. Koppes, Abigail N. Koppes Acta Biomaterialia.2021; 132: 325. CrossRef
Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats Nathalie Van Den Berge, Nelson Ferreira, Trine Werenberg Mikkelsen, Aage Kristian Olsen Alstrup, Gültekin Tamgüney, Páll Karlsson, Astrid Juhl Terkelsen, Jens Randel Nyengaard, Poul Henning Jensen, Per Borghammer Brain.2021; 144(6): 1853. CrossRef
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease Kari E. Murros, Vy A. Huynh, Timo M. Takala, Per E. J. Saris Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease Bipul Ray, Arehally M. Mahalakshmi, Sunanda Tuladhar, Abid Bhat, Asha Srinivasan, Christophe Pellegrino, Anbarasu Kannan, Srinivasa Rao Bolla, Saravana Babu Chidambaram, Meena Kishore Sakharkar Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, Pieter Van Den Abbeele, Arnout Bruggeman, Jawal Said, Barry Smith, Lynne Ann Barker, Caroline Jordan, Valentina Leta, K. Ray Chaudhuri, Abdul W. Basit, Simon Gaisford International Journal of Pharmaceutics: X.2021; 3: 100087. CrossRef
The Role of The Gut Microbiome in Parkinson’s Disease Amy Gallop, James Weagley, Saif-ur-Rahman Paracha, George Grossberg Journal of Geriatric Psychiatry and Neurology.2021; 34(4): 253. CrossRef
The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease Gianfranco Natale, Larisa Ryskalin, Gabriele Morucci, Gloria Lazzeri, Alessandro Frati, Francesco Fornai Life.2021; 11(8): 732. CrossRef
Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson’s disease mice by gut microbiome Jiajing Shan, Youge Qu, Siming Wang, Yan Wei, Lijia Chang, Li Ma, Kenji Hashimoto Brain Research Bulletin.2021; 177: 103. CrossRef
Cholecystectomy and subsequent risk of Parkinson’s disease: a nationwide retrospective cohort study Ryul Kim, Jee-Young Lee, Sanghyun Park, Kyungdo Han, Cheol Min Shin npj Parkinson's Disease.2021;[Epub] CrossRef
Benefits of Helicobacter pylori Eradication on Extragastric Diseases Tae Jun Kim, Hyuk Lee The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(4): 275. CrossRef
Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease Bartłomiej Sankowski, Karolina Księżarczyk, Emilia Raćkowska, Stanisław Szlufik, Dariusz Koziorowski, Joanna Giebułtowicz Clinica Chimica Acta.2020; 501: 165. CrossRef
The microbiome-gut-brain axis in acute and chronic brain diseases Corinne Benakis, Camille Martin-Gallausiaux, Jean-Pierre Trezzi, Philip Melton, Arthur Liesz, Paul Wilmes Current Opinion in Neurobiology.2020; 61: 1. CrossRef
The progress of gut microbiome research related to brain disorders Sibo Zhu, Yanfeng Jiang, Kelin Xu, Mei Cui, Weimin Ye, Genming Zhao, Li Jin, Xingdong Chen Journal of Neuroinflammation.2020;[Epub] CrossRef
Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities Ovidiu-Dumitru Ilie, Alin Ciobica, Jack McKenna, Bogdan Doroftei, Ioannis Mavroudis, Tuane B. Sampaio Oxidative Medicine and Cellular Longevity.2020; 2020: 1. CrossRef
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? Carolina Pellegrini, Luca Antonioli, Vincenzo Calderone, Rocchina Colucci, Matteo Fornai, Corrado Blandizzi Progress in Neurobiology.2020; 191: 101806. CrossRef
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease Hiroshi Nishiwaki, Mikako Ito, Tomohiro Ishida, Tomonari Hamaguchi, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori, Ken Kurokawa, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno Movement Disorders.2020; 35(9): 1626. CrossRef
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri Frontiers in Cell and Developmental Biology.2020;[Epub] CrossRef
Role of Carbon Monoxide in Host–Gut Microbiome Communication Christopher P. Hopper, Ladie Kimberly De La Cruz, Kristin V. Lyles, Lauren K. Wareham, Jack A. Gilbert, Zehava Eichenbaum, Marcin Magierowski, Robert K. Poole, Jakob Wollborn, Binghe Wang Chemical Reviews.2020; 120(24): 13273. CrossRef
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease Chrysoula Marogianni, Maria Sokratous, Efthimios Dardiotis, Georgios M. Hadjigeorgiou, Dimitrios Bogdanos, Georgia Xiromerisiou International Journal of Molecular Sciences.2020; 21(22): 8421. CrossRef
Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease Tennekoon B. Karunaratne, Chijioke Okereke, Marissa Seamon, Sharad Purohit, Chandramohan Wakade, Amol Sharma Nutrients.2020; 13(1): 28. CrossRef
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder Hiroshi Nishiwaki, Tomonari Hamaguchi, Mikako Ito, Tomohiro Ishida, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori, Ken Kurokawa, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno, Chaysavanh Manichanh mSystems.2020;[Epub] CrossRef
The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge Sven C. D. van IJzendoorn, Pascal Derkinderen, Teus van Laar Journal of Parkinson's Disease.2019; 9(s2): S323. CrossRef
Medical management, prevention and mitigation of environmental risks factors in Neurology J. Reis, G.C. Román, M. Giroud, V.S. Palmer, P.S. Spencer Revue Neurologique.2019; 175(10): 698. CrossRef
Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain Yaoyu Pu, Lijia Chang, Youge Qu, Siming Wang, Kai Zhang, Kenji Hashimoto Aging.2019; 11(17): 6915. CrossRef